These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26718588)

  • 1. Noradrenergic-Dopaminergic Interactions Due to DSP-4-MPTP Neurotoxin Treatments: Iron Connection.
    Archer T
    Curr Top Behav Neurosci; 2016; 29():73-86. PubMed ID: 26718588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal iron overload destroys NA-DA functional interactions.
    Fredriksson A; Archer T
    J Neural Transm (Vienna); 2007 Feb; 114(2):195-203. PubMed ID: 16932993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment.
    Nowak P
    Curr Top Behav Neurosci; 2016; 29():51-71. PubMed ID: 26427851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.
    Marien M; Briley M; Colpaert F
    Eur J Pharmacol; 1993 Jun; 236(3):487-9. PubMed ID: 7689466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.
    Thomas B; von Coelln R; Mandir AS; Trinkaus DB; Farah MH; Leong Lim K; Calingasan NY; Flint Beal M; Dawson VL; Dawson TM
    Neurobiol Dis; 2007 May; 26(2):312-22. PubMed ID: 17336077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.
    Archer T; Fredriksson A
    Neurochem Res; 2007 Oct; 32(10):1625-39. PubMed ID: 17694434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice.
    Wang QM; Xu YY; Liu S; Ma ZG
    Oncotarget; 2017 Jul; 8(29):47284-47295. PubMed ID: 28521299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of noradrenaline denervation on MPTP-induced deficits in mice.
    Archer T; Fredriksson A
    J Neural Transm (Vienna); 2006 Sep; 113(9):1119-29. PubMed ID: 16362627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H; Underwood R; Lavalley N; Yacoubian TA
    Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
    Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
    J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice.
    Fornai F; Giorgi FS; Gesi M; Chen K; Alessrì MG; Shih JC
    Synapse; 2001 Mar; 39(3):213-21. PubMed ID: 11169770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment on ovarian development of the sapphire devil, Chrysiptera cyanea.
    Badruzzaman M; Imamura S; Takeuchi Y; Ikegami T; Takemura A
    Fish Physiol Biochem; 2015 Feb; 41(1):61-71. PubMed ID: 25362562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Pflibsen L; Stang KA; Sconce MD; Wilson VB; Hood RL; Meshul CK; Mitchell SH
    J Neurosci Res; 2015 Dec; 93(12):1849-64. PubMed ID: 26332770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
    Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
    Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.